STAR-0215

· Astria Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for STAR-0215, covering 2025-04-11 to 2025-07-23. Get the full timeline:

Most recent: Clinical Trial Update: A Long-term Study of STAR-0215 in Participants With Hereditary Angioedema [Phase 2]